Stoke Therapeutics, Inc. short interest in 2022
In 2022, Stoke Therapeutics, Inc.'s disclosed short interest ran from 8.42% of shares outstanding on 14 Jan 2022 to 9.73% on 30 Dec 2022, a change of +1.31 percentage points. The year's high was 16.53% on 14 Apr 2022 and its low 8.42% on 14 Jan 2022, averaging 13.07% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 53.08 days on 15 Jul 2022. Full history: Stoke Therapeutics, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2022 in figures
- Start of year
- 8.42% (14 Jan 2022)
- End of year
- 9.73% (30 Dec 2022)
- Change
- +1.31 pp
- High
- 16.53% (14 Apr 2022)
- Low
- 8.42% (14 Jan 2022)
- Average
- 13.07%
- Highest days to cover
- 53.08 (15 Jul 2022)
- SEC filings marked
- 9
Every report in 2022
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 14 Jan 2022 | 8.42% | 11.75 | results (8-K) |
| 31 Jan 2022 | 9.89% | 8.49 | |
| 15 Feb 2022 | 9.91% | 9.73 | |
| 28 Feb 2022 | 11.59% | 16.43 | |
| 15 Mar 2022 | 14.33% | 20.49 | 10-K filed, results (8-K) |
| 31 Mar 2022 | 15.54% | 12.72 | |
| 14 Apr 2022 | 16.53% | 22.72 | |
| 29 Apr 2022 | 16.52% | 34.29 | |
| 13 May 2022 | 15.48% | 16.25 | 10-Q filed, results (8-K) |
| 31 May 2022 | 15.78% | 19.65 | |
| 15 Jun 2022 | 15.85% | 16.47 | |
| 30 Jun 2022 | 16.15% | 14.61 | |
| 15 Jul 2022 | 15.64% | 53.08 | |
| 29 Jul 2022 | 14.52% | 23.13 | |
| 15 Aug 2022 | 13.29% | 27.01 | 10-Q filed, results (8-K) |
| 31 Aug 2022 | 13.55% | 31.55 | |
| 15 Sep 2022 | 13.35% | 18.04 | |
| 30 Sep 2022 | 13.82% | 24.28 | |
| 14 Oct 2022 | 13.06% | 19.47 | |
| 31 Oct 2022 | 11.64% | 16.73 | |
| 15 Nov 2022 | 10.70% | 9.54 | 10-Q filed, results (8-K) |
| 30 Nov 2022 | 9.27% | 8.33 | |
| 15 Dec 2022 | 9.14% | 13.32 | |
| 30 Dec 2022 | 9.73% | 16.26 |
See also: Stoke Therapeutics, Inc.'s full history · most shorted US stocks of 2022 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.